Concepedia

Takeshi Kitazaki

TK

25

Publications

1.5K

Citations

18

H-Index

2003

Active since

Affiliations

Nagasaki University(Current)

Japanese Red Cross Society, Japan

Nagasaki University Hospital

Oita University

Kawasaki Medical School

Takeshi Kitazaki is an author at Nagasaki University specializing in medicine, oncology, and lung cancer.

Top concepts

Publications per year

2003–2020

25

Publications

25

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang et al. · Nature Communications · 2019 · 351 citations · Full text

Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells

Takeshi Kitazaki, Mikio Oka, Yoichi Nakamura et al. · Lung Cancer · 2005 · 177 citations

, , +5

Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance

Yoichi Nakamura, Mikio Oka, Hiroshi Soda et al. · Cancer Research · 2005 · 177 citations · Full text

Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

Ken Shiozawa, Mikio Oka, Hiroshi Soda et al. · International Journal of Cancer · 2003 · 119 citations

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer

Naoko Okura, Naoya Nishioka, Tadaaki Yamada et al. · Clinical Cancer Research · 2020 · 108 citations

Rows per page

1–5 of 25